Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
6.73
+0.67 (10.97%)
At close: May 15, 2025, 4:00 PM
6.82
+0.10 (1.41%)
Pre-market: May 16, 2025, 5:03 AM EDT
Rocket Pharmaceuticals Stock Forecast
RCKT's stock price has decreased by -71.24% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Rocket Pharmaceuticals stock ranges from a low of $13 to a high of $65. The average analyst price target of $41.7 forecasts a 520.07% increase in the stock price over the next year.
Price Target: $41.70 (+520.07%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rocket Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 5 | 5 | 4 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $52 → $51 | Buy | Maintains | $52 → $51 | +658.36% | May 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +405.58% | May 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $54 → $45 | Strong Buy | Maintains | $54 → $45 | +569.14% | May 9, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $45 → $44 | Buy | Maintains | $45 → $44 | +554.28% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +93.31% | May 9, 2025 |
Financial Forecast
Revenue This Year
n/a
from 803.41M
Revenue Next Year
n/a
EPS This Year
-2.42
from -2.73
EPS Next Year
-1.66
from -2.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 233.1M | 562.9M | 1.2B | ||
| Avg | 48.7M | 133.5M | 405.2M | ||
| Low | n/a | 7.3M | 18.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -71.0% | 1,057.1% | 764.5% | ||
| Avg | -93.9% | 174.4% | 203.5% | ||
| Low | - | -85.0% | -86.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.44 | -0.04 | 2.32 | ||
| Avg | -2.42 | -1.66 | 0.13 | ||
| Low | -3.30 | -2.46 | -1.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.